Clinical Decision Support Systems (CDSS) Market

Market Overview:

The global clinical decision support systems (CDSS) market size reached US$ 1.50 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.36 Billion by 2028, exhibiting a CAGR of 7.70% during 2023-2028. The increasing demand for service-oriented intelligent healthcare decision-making software and the rising instances of medical errors represent some of the key factors driving the market. 

The clinical decision support system (CDSS) refers to a specialized information computer-based application designed to analyze data within electronic health record (EHR) record systems. It provides reminders to clinicians, physicians, and staff to suggest better clinical treatments for effective patient care. It employs various hardware and software-based solutions, such as cloud storage, which helps manage and store an excessive amount of accessible clinical and administrative data. CDSS assists in enhancing healthcare delivery by making complex medical decisions with targeted clinical and health-related information, streamlines the workflow, inhibits the risk of medication errors, reduces misdiagnoses, and helps in executing diverse administrative operations. Apart from this, it manages medical practices, provides reliable information and observations, and optimizes overall operational efficiency. As a result, CDSS is used by hospitals and clinics to provide drug allergy alerts and ensure better clinical outcomes by providing exceptional care to patients.

The increasing need for various advanced systems with specialized algorithms, interactive interfaces, and service-oriented architectures, including CDSS solutions to treat several chronic disorders, is primarily driving the market toward growth. In line with this, the escalating instances of medication errors due to human intervention have intensified the widespread adoption of CDSS in the healthcare sector to make better clinical decisions, which is acting as another growth-inducing factor. Additionally, favorable initiatives undertaken by governments of various countries to promote the uptake of health information and communication technology (HICT) in hospital settings are favoring the market growth. Such products help provide high-quality care to patients at lower expenditure by furnishing health workers with reliable data. Moreover, the large-scale integration of artificial intelligence (AI), machine learning (ML), computerized provider order entry (CPOE), and statistical pattern recognition solutions to analyze data measurements for extracting information is propelling the market growth. These technologies can be further administered through multiple consumer electronic devices, such as desktops, tablets, biometric monitoring systems, and wearable devices, which is impelling the market growth. Apart from this, significant enhancements in the healthcare infrastructure, growing consumer awareness regarding its availability and beneficial properties, and ongoing mergers and acquisitions (M&A) amongst key players to engineer advanced CDSS solutions are creating a positive outlook for the market. 

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the clinical decision support systems (CDSS) market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on component, product, type, delivery mode, model, and application.

Component Insights 

• Hardware
• Software
• Services
   

The report has provided a detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the component. This includes hardware, software and services. According to the report, services represented the largest segment.

Product Insights

• Integrated CDSS
• Standalone CDSS
   

A detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the product has also been provided in the report. This includes integrated and standalone CDSS. According to the report, integrated CDSS accounted for the largest market share.

Type Insights

• Therapeutic
• Diagnostic
   

The report has also provided a detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the type. This includes therapeutic and diagnostic. According to the report, therapeutic represented the largest segment. 

Delivery Mode Insights

• On Premise
• Cloud Based
   

A detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the delivery mode has also been provided in the report. This includes on premise and cloud based. According to the report, on-premise accounted for the largest market share.

Model Insights

• Knowledge Based
• Non-Knowledge Based
   

The report has also provided a detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the model. This includes knowledge and non-knowledge based. According to the report, knowledge based represented the largest segment. 

Application Insights 

• Drug Allergy Alerts
• Clinical Guidelines
• Drug-Drug Interactions
• Clinical Reminders
• Others
   

A detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the application has also been provided in the report. This includes drug allergy alerts, clinical guidelines, drug-drug interactions, clinical reminders and others. According to the report, drug allergy alert accounted for the largest market share. 

Regional Insights

• North America
  • United States
  • Canada
• Europe 
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for clinical decision support systems. Some of the factors driving the North America clinical decision support system market included the increasing demand for service-oriented intelligent healthcare decision-making software and the rising instances of medical errors.

Competitive Landscape

The report has also provided a comprehensive analysis of the competitive landscape in the global clinical decision support system market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Athenahealth Inc., Change Healthcare (United Health Group Incorporated), Epic Systems Corporation, General Electric Company, International Business Machines Corporation, Koninklijke Philips N.V., NextGen Healthcare Inc., Oracle Corporation, Siemens Healthineers AG (Siemens AG), Wolters Kluwer N.V., Zynx Health Incorporated (Hearst Business Media Corporation), etc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Report Coverage:

Key Questions Answered in This Report: 

• How has the global clinical decision support systems (CDSS) market performed so far and how will it perform in the coming years? 
• What are the drivers, restraints, and opportunities in the global clinical decision support systems (CDSS) market? 
• What are the key regional markets? 
• Which countries represent the most attractive clinical decision support systems (CDSS) markets?  
• What is the breakup of the market based on the component? 
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the delivery mode?
• What is the breakup of the market based on the model?
• What is the breakup of the market based on the application? 
• What is the competitive structure of the global clinical decision support systems (CDSS) market? 
• Who are the key players/companies in the global clinical decision support systems (CDSS) market?
   

Key Benefits for Stakeholders:?

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the clinical decision support systems (CDSS) market from 2017-2028.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the global clinical decision support systems (CDSS) market.
• The study maps the leading as well as the fastest growing regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the clinical decision support systems (CDSS) industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.